European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

MT Newswires Live10-31

European equities traded in the US as American depositary receipts were falling significantly lower late Thursday morning, dropping 1.4% to 1,347.70 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications (SQNS), which rose 3.8% and 2.6% respectively. They were followed by financial services company Banco Santander (SAN) and internet advertising firm Criteo (CRTO), which were up 2.1% and 2% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and brewing company Anheuser-Busch InBev (BUD), which lost 12% and 5.8% respectively. They were followed by 3D printer company Materialise (MTLS) and petroleum refiner Equinor (EQNR), which dropped 3.1% and 2.7% respectively.

From the UK and Ireland, the gainers were led by oil and gas company Shell (SHEL) and Adaptimmune Therapeutics (ADAP), which increased 1.7% and 0.9% respectively. They were followed by tobacco company British American Tobacco (BTI) and cruise line operator Carnival (CUK), which advanced 0.8% and 0.6% respectively.

The decliners from the UK and Ireland were led by medical device maker Smith & Nephew (SNN) and biopharmaceutical company TC Biopharm (TCBP), which tumbled 13.3% and 6.8% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which fell 4% and 2.6% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment